Abstract:Aim of the study: Icaritin is an active ingredient extracted from the plant Herba Epimedium Sagittatum (Sieb. et Zucc.) Maxim. The purpose of this study is to investigate the effects and mechanisms of icaritin-induced cell death in activated hepatic stellate cells (HSCs) and ameliorating the development of liver fibrosis in rats.Materials and methods: : In vitro, icaritin-induced cell death rates in HSC-T6 (rat) and LX-2 (human) HSC lines as well as normal hepatocyte cell lines HL-7702 (L02) and WRL-68 were assayed by MTT method, and the apoptotic ratios were detected by both flow cytometry and the Annexin-V-FITC Apoptosis Detection Kit. A Whole Rat Genome Microarray Kit was used to identify expression of interest genes through fold-change screening. In vivo study, experimental liver fibrosis models were built by carbon tetrachloride (CCl4) or common bile duct ligation (CBDL) in Wistar rats. Icaritin (1 mg/kg/day, three days a week) was administered by gastric gavage for four weeks (n = 6 per group). At the end of the study, serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) as well as the contents of hydroxyproline and collagen 1 in liver tissues were measured. Histopathological changes and the distribution of activated HSCs were observed in the liver tissues using hematoxyline-eosin (HE) staining and immunohistochemical staining for alpha-smooth muscle actin (alpha-SMA).Results: Icaritin induced apoptosis in HSC-T6 and LX-2 in a concentration- and time-dependent manner with little toxicity to normal hepatocyte cell lines. The IC50 of icaritin in HSC-T6 was 12.83 mu M at 48 h. Apoptotic ratio of HSC-T6 treated with 24 mu M icaritin was 20.19%, and the G2 phase of the cell cycle did not occur (P < 0.05). Gene analysis showed that icaritin up-regulated Bak-1, Bmf and Bax expression while significantly down-regulated Bcl-2 expression (vs. control group, P < 0.01). These results suggested that mitochondrial pathway played an important role in icaritin-induced apoptosis in activated HSCs. In vivo results showed that icaritin reduced the number of activated HSCs, and brought the elevated levels of AST, ALT, hydroxyproline and collagen I to normal or near normal values (vs. model group, P < 0.05).Conclusions: Icaritin can induce cell death in activated HSCs through mitochondria-mediated apoptosis, ameliorate the progression of hepatic fibrosis in rats, and could be a promising drug for treating liver fibrosis. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.

Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer.

Icaritin Promotes Apoptosis and Inhibits Proliferation by Down-Regulating AFP Gene Expression in Hepatocellular Carcinoma

The Effect of Icariin on Human Hepatoellular Carcinomas Cell Apoptosis and Cell Cycle Arrest

Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells.

The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors.

Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.

Icaritin Induces Ovarian Cancer Cell Apoptosis Through Activation of P53 and Inhibition of Akt/mTOR Pathway

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Antitumor Effects of Icaritin and the Molecular Mechanisms.

Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways

Icaritin promotes tumor T‐cell infiltration and induces antitumor immunity in mice

Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation

Reactive Oxygen Species Induced by Icaritin Promote DNA Strand Breaks and Apoptosis in Human Cervical Cancer Cells

Induction of ROS and DNA Damage-Dependent Senescence by Icaritin Contributes to Its Antitumor Activity in Hepatocellular Carcinoma Cells

Icaritin Induces Cell Death in Activated Hepatic Stellate Cells Through Mitochondrial Activated Apoptosis and Ameliorates the Development of Liver Fibrosis in Rats

New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives

Anti-Proliferative Efficacy of Icariin on HepG2 Hepatoma and Its Possible Mechanism of Action

Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition